End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Timothy Walbert
CEO | Chief Executive Officer | 57 | 01/08/01 |
Aaron Cox
DFI | Director of Finance/CFO | 41 | 01/16/01 |
Karin Rosen
CTO | Chief Tech/Sci/R&D Officer | 57 | 02/20/02 |
Vikram Karnani
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/14/01 |
Chief Tech/Sci/R&D Officer | 66 | 01/16/01 | |
Jeffrey Sherman
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/09/01 |
Keli Walbert
SAM | Sales & Marketing | - | 01/18/01 |
Comptroller/Controller/Auditor | 45 | 01/15/01 | |
David Caraher
SEC | Corporate Secretary | - | - |
Jane Gonnerman
HRO | Human Resources Officer | - | 01/21/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Walbert
CEO | Chief Executive Officer | 57 | 01/08/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 229,378,934 | 226,691,767 ( 98.83 %) | 384,366 ( 0.1676 %) | 98.83 % |
Company contact information
Horizon Therapeutics Plc
70 St. Stephen's Green
4, Dublin
+353 1 772 2100
http://www.horizontherapeutics.comGroup companies
Name | Category and Sector |
---|---|
Horizon Pharma Treasury Ltd.
|
Sector
1st Jan change | Capi. | |
---|---|---|
+29.63% | 682B | |
+30.35% | 586B | |
-3.81% | 364B | |
+17.45% | 327B | |
+3.34% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+7.24% | 165B |
- Stock Market
- Equities
- HZNP Stock
- Stock
- Company Horizon Pharma Inc